| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC11056 | Baloxavir marboxil Featured | Baloxavir marboxil is a prodrug of S-033447. S-033447 is a small molecule inhibitor of the cap-dependent endonuclease of influenza A and B viruses. |
|
| DC9486 | Nucleozin Featured | Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication. |
|
| DCAPI1594 | Oseltamivir phosphate Featured | OSELTAMIVIR is an active (orally) inhibitor of the influenze virus neuraminidase and converted to the active acid metabolite in vivo. |
|
| DCAPI1121 | Peramivir | Peramivir |
|
| DCAPI1010 | Peramivir Trihydrate Featured | Peramivir, also known as BCX1812 and RWJ 270201, is an antiviral drug for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir was approved to treat influenza infection in adults. |
|
| DC9815 | Pimodivir(VX-787） Featured | Pimodivir(VX-787) is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. |
|
| DC5105 | Favipiravir (T-705) Featured | T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.T 705(Favipiravir) is useful for Antiviral agents. |
|
| DC8429 | Verdinexor (KPT-335) Featured | Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor. |
|
| DCAPI1063 | Zanamivir (Relenza) Featured | Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively. |
|
